State of secondary prevention in Czech coronary patients in the EUROASPIRE IV study-Reference-Cited by-同舟云学术

State of secondary prevention in Czech coronary patients in the EUROASPIRE IV study

Published:2014-04-01 Issue:2 Volume:56 Page:e105-e112
ISSN:0010-8650
Container-title:Cor et Vasa
language:
Short-container-title:Cor Vasa

Author:

Bruthans Jan,Mayer Otto,Galovcová Markéta,Seidlerová Jitka,Bělohoubek Jiří,Timoracká Katarína,Vagovičová Petra,Adámková Věra,Vaněk Jiří,Filipovský Jan,Cífková Renata

Publisher

Czech Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine

Link

http://e-coretvasa.cz/doi/10.1016/j.crvasa.2014.02.012.pdf

Reference19 articles.

1. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

2. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

3. EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results

4. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme

5. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology;Current Atherosclerosis Reports;2022-03-25

2. Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study;Cor et Vasa;2019-06-21

3. Why do we fail when treating dyslipidemia?;Interní medicína pro praxi;2018-10-01